the RACE for Children Act would provide that a drug company will provide a pediatric study plan of a drug pursuant to the Pediatric Research Equity Act if the drug is, 'intended for the treatment of an adult cancer and is directed at a molecular target considered to be germane to the growth and progression of such pediatric cancer.'
Butterfield discusses the RACE for Children Act aimed at improving pediatric cancer drug access.
Share
More from G. K. Butterfield
May I inquire about how much time each side has remaining. The SPEAKER pro tempore (Ms. Clark of Massachusetts). The gentleman from North Carolina has 6\1/2\ minutes remaining. The gentleman from Illinois has 2\1/4\ minutes remaining.
Where we diverge is how to preserve the program for those in actual need without regulatory loopholes and fuzzy interpretations of the law, both of which exploit the very intent of the program.
I include in the Record the following letters of support for the Senate Amendment to H.R. 5746. National Urban League, New York, NY, January 13, 2022. Dear Representative: As President and CEO of the National Urban League, and on behalf of…
At this time in the interest of time, I yield 30 seconds to the gentleman from Texas (Mr. Allred), my friend from Dallas, who represents the 32nd Congressional District.
Other voices in this conversation
